Burden of Multiple Sclerosis in Eastern Mediterranean Region (1990-2016): Findings From the 2016 Global Burden of Disease Study
Preprint
Abstract
Background Multiple sclerosis (MS) is among the leading causes of disability in Young Adults worldwide. Current estimates of MS burden in Eastern Mediterranean Region (EMR) are necessary for planning effective interventions .To estimate Prevalence, incidence, mortality, years lived with disability (YLDs), years of life lost (YLLs) and disability-adjusted life-years (DALYs) in EMR by country age, and sex from 1990 to 2016. Methods We estimated regional and country-specific prevalence, incidence, mortality, DALYs, YLLs, and YLDs for MS. DALYs were computed as the sum of YLDs and YLLs. Results Total DALYs in EMR countries was 12,810 in 1990 for males and increased to 36,391 in 2016 and from 18,962 to 53,851 for females. Lowest DALYs in both sexes were observed in Somalia (248) while the highest were in Iran (26,394). YLDs in males increased from 6,511 in 1990 to 19,515 in 2016, and in females from 12,247 to 33,937. The highest age-standardized prevalence, incidence, YLDs and DALYs were in Iran (72.11, 2.49, 18.03, and 32.5, respectively). Conclusions Our findings provide valuable information to guide the development and implementation of measures to address the rising burden of MS and it consequences in the EMR countries.Keywords
This publication has 16 references indexed in Scilit:
- Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016The Lancet, 2017
- Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016The Lancet, 2017
- Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016The Lancet, 2017
- Mortality trends for multiple sclerosis patients in Sweden from 1968 to 2012Neurology, 2017
- New insights into the burden and costs of multiple sclerosis in EuropeMultiple Sclerosis Journal, 2017
- Multiple Sclerosis Epidemiology in East Asia, South East Asia and South Asia: A Systematic ReviewNeuroepidemiology, 2016
- Multiple Sclerosis Epidemiology in Middle East and North Africa: A Systematic Review and Meta-AnalysisNeuroepidemiology, 2015
- Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequityNeurology, 2014
- Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoringBMC Neurology, 2014
- Characteristics of multiple sclerosis in the Middle East with special reference to the applicability of international guidelines to the regionInternational Journal of Neuroscience, 2013